A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patientsSara Rossi, Giuseppe Campiani, Silvia Pasquini et al.|Biomedicine & Pharmacotherapy|2024Cited by 9
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood MalignanciesGabriele Carullo, Giuseppe Campiani, Sara Rossi et al.|ACS Pharmacology & Translational Science|2024Cited by 7
Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonistFederica Cherchi, Anna Maria Pugliese, L. Frulloni et al.|Neuropharmacology|2025Cited by 0